Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin

作者： Panchanan Maiti1,2,3,4,5, Alexandra Plemmons1, Zackary Bowers2,3, Charles Weaver5, Gary Dunbar1,2,3,4 1Field Neurosciences Institute,Ascension St. Mary's Hospital, 2Field Neurosciences Institute Laboratory for Restorative Neurology,Central Michigan University, 3Program in Neuroscience,Central Michigan University, 4Department of Psychology,Central Michigan University, 5Department of Health Sciences,Saginaw Valley State University

简介：

Overview

This article outlines a protocol using curcumin as a fluorophore for efficient labeling and imaging of amyloid beta protein plaques in brain tissue. Curcumin demonstrates preferential binding to amyloid plaques, making it a cost-effective alternative to traditional amyloid-specific antibodies.

Key Study Components

Area of Science

• Neuroscience
• Alzheimer's disease research
• Imaging techniques

Background

• Amyloid beta plaques are key markers in Alzheimer's disease.
• Traditional labeling methods involve expensive and time-consuming antibody-based techniques.
• Curcumin's structural similarities to traditional amyloid binding dyes enhance its application.
• Curcumin also binds to tau tangles and other disease-related proteins.

Purpose of Study

• To present a protocol for labeling beta-amyloid plaques using curcumin.
• To demonstrate the method’s efficiency compared to gold-standard techniques.
• To facilitate noninvasive imaging applications like PET scans and retinal screening.

Methods Used

• The protocol involves perfusion of animal brain tissues for fluorescence imaging.
• Key biological models include 12-month-old Alzheimer’s disease model mice.
• Low-temperature embedding and cryostat sectioning are employed for brain samples.
• Critical steps include precise perfusion and washing protocols to avoid background signal interference.
• Curcumin labeling is done with specific incubation periods and washing protocols.

Main Results

• Curcumin effectively labels amyloid beta protein plaques with high specificity and low background.
• The method provided results comparable in quality to traditional labeling without the high costs.
• Amplified signal visibility assists in imaging techniques, including fluorescence microscopy.

Conclusions

• This study provides a cost-effective and efficient technique for amyloid plaque imaging.
• The findings highlight the potential of curcumin in various neurological disease models.
• Implications extend to noninvasive screening methods, enhancing accessibility for research.

Frequently Asked Questions